Gilada Finance approves JV with Harley of London India and NCDs
Gilada Finance and Investments Limited's board approved a strategic joint venture with Harley of London India for collaboration in healthcare and financial services. The company also allotted 5 non-convertible debentures aggregating ₹5,00,000 at a 12.25% coupon rate for a 2-year tenure. Anand Boob & Associates were appointed as internal auditors for FY26-27.

*this image is generated using AI for illustrative purposes only.
Gilada Finance and Investments Limited approved a strategic joint venture with Harley of London India to collaborate in healthcare, wellness, and financial services. The board also approved the allotment of Non-Convertible Debentures (NCDs) worth ₹5,00,000 on a private placement basis to raise capital. These decisions were taken during a board meeting held on June 19, 2026.
The board authorized Managing Director Mr. Raigopal Gilada to finalize and execute the Joint Venture Agreement with Harley of London India, sponsored by the Delamore & Owl Group. The partnership aims to leverage the HOLNESS ecosystem for business initiatives across various sectors.
The company allotted 5 NCDs of face value ₹1,00,000 each at a coupon rate of 12.25% per annum. The debt instruments have a tenure of 2 years and are non-cumulative in nature.
| Particulars | Details |
|---|---|
| Date of Allotment | June 19, 2026 |
| Type of Security | Non-Convertible Debentures (NCDs) |
| Nature | Non-Cumulative |
| Number of NCDs Allotted | 5 |
| Aggregate Amount | ₹5,00,000 |
| Rate of Interest | 12.25% per annum |
| Tenure | 2 Years |
Additionally, the board appointed Anand Boob & Associates as the internal auditor for the financial year 2026-27. The disclosure was submitted to BSE Limited under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Gilada Finance & Investments
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.98% | -1.77% | +11.50% | +1.61% | +17.56% | +37.23% |
How will the joint venture with Harley of London India specifically impact Gilada Finance's revenue streams in the next fiscal year?
What are the potential risks associated with the high coupon rate of 12.25% on the newly issued NCDs?
Could the partnership with Harley of London India lead to further collaborations in other sectors beyond healthcare and wellness?





























